This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Huberman, E. Articles by Slaga, T. J. Search for Related Content PubMed PubMed Citation Articles by Huberman, E. Articles by Slaga, T. J.

Mutagenicity and Tumor-initiating Activity of Fluorinated Derivatives of 7,12-Dimethylbenz(a)anthracene¹

Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830

7,12-Dimethylbenz(a)anthracene (DMBA) and its 1-, 2-, 5-, and 11-fluoro derivatives were tested to determine their mutagenicity for ouabain resistance in Chinese hamster V79 cells and their tumor-initiating activity in mouse skin. Inasmuch as V79 cells do not metabolize polycyclic aromatic hydrocarbons, mutagenesis was tested both in the presence and in the absence of golden hamster embryo cells capable of metabolizing polycyclic aromatic hydrocarbons. Neither DMBA nor any of the fluorinated derivatives showed mutagenicity for V79 cells in the absence of the golden hamster cells. In the presence of these cells, DMBA and 11-fluoro-DMBA exhibited a comparable mutagenic response that was dose dependent. At a dose as low as 0.01 µM, a 7- to 10-fold increase in the frequency of ouabainresistant mutants was observed. The other derivatives were either inactive or required more than a 1000-fold higher dose to induce a comparable mutagenic response. Similarly, both DMBA and 11-fluoro-DMBA at 100 nmol initiated tumors in 100% of the tested mice, whereas the other fluorinated derivatives at this dose initiated skin tumors in 15% or less of the treated mice. The average number of papillomas per mouse induced by 1-, 2-, and 5-fluoro-DMBA was more than 100-fold lower than the number induced by DMBA or 11-fluoro-DMBA. These results suggest that carbon positions 1 and 2 of DMBA, which are located at the "bay region," and position 5, which is located at the "K-region," are involved in the metabolic activation of DMBA into mutagenic and carcinogenic metabolites.

¹ This work was sponsored jointly by the National Cancer Institute under Interagency Agreement 40-636-77, Contract Y01 CP 70222, and the Division of Biomedical and Environmental Research, United States Department of Energy, under Contract W-7405-eng-26 with the Union Carbide Corporation.

Received 8/11/78. Accepted 10/25/78.